Medicine
Clinical analysis of converting cyclosporine-based immunosuppressant regimen to tacrolimus with mycophenolate mofetil in renal transplantation patients with chronic allograft nephropathy
Li Liu-yang
tlooto Summary
Converting to FK506+MMF from CsA-based immunosuppressant regimen is safe and effective in treating renal transplantation patients with chronic allograft nephropathy, suggesting that reducing the amount of 24-hour urine protein excretion was reduced compared with the pre-conversion.
Abstract
Abstract is not available.
Citation format
LIU-YANG, Li. Clinical analysis of converting cyclosporine-based immunosuppressant regimen to tacrolimus with mycophenolate mofetil in renal transplantation patients with chronic allograft nephropathy. Organ Transplantation, 2010.